These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 31314589

  • 1. Role of Intravoxel Incoherent Motion in Discriminating Hepatitis B Virus-Related Intrahepatic Mass-Forming Cholangiocarcinoma from Hepatocellular Carcinoma Based on Liver Imaging Reporting and Data System v2018.
    Shao S, Shan Q, Zheng N, Wang B, Wang J.
    Cancer Biother Radiopharm; 2019 Oct; 34(8):511-518. PubMed ID: 31314589
    [Abstract] [Full Text] [Related]

  • 2. Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma: Comparison with conventional diffusion-weighted imaging.
    Zhu SC, Liu YH, Wei Y, Li LL, Dou SW, Sun TY, Shi DP.
    World J Gastroenterol; 2018 Feb 28; 24(8):929-940. PubMed ID: 29491686
    [Abstract] [Full Text] [Related]

  • 3. Value of Intravoxel Incoherent Motion (IVIM) Imaging for Differentiation between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
    Wang J, Yang Z, Luo M, Xu C, Du M, Liu Y.
    Contrast Media Mol Imaging; 2022 Feb 28; 2022():1504463. PubMed ID: 35615729
    [Abstract] [Full Text] [Related]

  • 4. Intravoxel incoherent motion diffusion-weighted imaging to differentiate hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Peng J, Zheng J, Yang C, Wang R, Zhou Y, Tao YY, Gong XQ, Wang WC, Zhang XM, Yang L.
    Sci Rep; 2020 May 07; 10(1):7717. PubMed ID: 32382050
    [Abstract] [Full Text] [Related]

  • 5. Evaluating histologic differentiation of hepatitis B virus-related hepatocellular carcinoma using intravoxel incoherent motion and AFP levels alone and in combination.
    Shan Q, Chen J, Zhang T, Yan R, Wu J, Shu Y, Kang Z, He B, Zhang Z, Wang J.
    Abdom Radiol (NY); 2017 Aug 07; 42(8):2079-2088. PubMed ID: 28337521
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection.
    Shao S, Liang Y, Kuang S, Chen J, Shan Q, Yang H, Zhang Y, Wang B, J Fowler K, Wang J, B Sirlin C.
    Bosn J Basic Med Sci; 2020 Aug 03; 20(3):401-410. PubMed ID: 31999940
    [Abstract] [Full Text] [Related]

  • 7. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI.
    Radiology; 2014 Mar 03; 270(3):758-67. PubMed ID: 24475811
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.
    Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK.
    J Magn Reson Imaging; 2016 Nov 03; 44(5):1330-1338. PubMed ID: 27087012
    [Abstract] [Full Text] [Related]

  • 9. The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    Kovač JD, Daković M, Janković A, Mitrović M, Dugalić V, Galun D, Đurić-Stefanović A, Mašulović D.
    PLoS One; 2021 Nov 03; 16(2):e0247301. PubMed ID: 33606753
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of monoexponential versus biexponential models of diffusion-weighted imaging in differentiating histologic grades of hepatitis B virus-related hepatocellular carcinoma.
    Shan Q, Kuang S, Zhang Y, He B, Wu J, Zhang T, Wang J.
    Abdom Radiol (NY); 2020 Jan 03; 45(1):90-100. PubMed ID: 31595327
    [Abstract] [Full Text] [Related]

  • 11. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X, Luo Y, Li Z, Hu Y, Li H, Tang H, Shen Y, Hu D, Kamel IR.
    J Magn Reson Imaging; 2019 Apr 03; 49(4):975-983. PubMed ID: 30277628
    [Abstract] [Full Text] [Related]

  • 12. Can IVIM help predict HCC recurrence after hepatectomy?
    Zhang Y, Kuang S, Shan Q, Rong D, Zhang Z, Yang H, Wu J, Chen J, He B, Deng Y, Roberts N, Shen J, Venkatesh SK, Wang J.
    Eur Radiol; 2019 Nov 03; 29(11):5791-5803. PubMed ID: 30972544
    [Abstract] [Full Text] [Related]

  • 13. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI?
    Lee HS, Kim MJ, An C.
    Eur Radiol; 2019 May 03; 29(5):2408-2416. PubMed ID: 30552477
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
    Kakite S, Dyvorne H, Besa C, Cooper N, Facciuto M, Donnerhack C, Taouli B.
    J Magn Reson Imaging; 2015 Jan 03; 41(1):149-56. PubMed ID: 24415565
    [Abstract] [Full Text] [Related]

  • 15. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
    Wu H, Liang Y, Wang Z, Tan C, Yang R, Wei X, Jiang X.
    Acta Radiol; 2023 Mar 03; 64(3):926-935. PubMed ID: 35898164
    [Abstract] [Full Text] [Related]

  • 16. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018.
    Zou X, Luo Y, Morelli JN, Hu X, Shen Y, Hu D.
    Abdom Radiol (NY); 2021 Jul 03; 46(7):3168-3178. PubMed ID: 33660040
    [Abstract] [Full Text] [Related]

  • 17. Characterizing focal hepatic lesions by free-breathing intravoxel incoherent motion MRI at 3.0 T.
    Watanabe H, Kanematsu M, Goshima S, Kajita K, Kawada H, Noda Y, Tatahashi Y, Kawai N, Kondo H, Moriyama N.
    Acta Radiol; 2014 Dec 03; 55(10):1166-73. PubMed ID: 24316660
    [Abstract] [Full Text] [Related]

  • 18. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
    Zheng W, Huang H, She D, Xiong M, Chen X, Lin X, Cao D.
    Abdom Radiol (NY); 2022 Mar 03; 47(3):957-968. PubMed ID: 34964069
    [Abstract] [Full Text] [Related]

  • 19. Value of Intravoxel Incoherent Motion for Hepatocellular Carcinoma Grading.
    Sokmen BK, Sabet S, Oz A, Server S, Namal E, Dayangac M, Dogusoy GB, Tokat Y, Inan N.
    Transplant Proc; 2019 Mar 03; 51(6):1861-1866. PubMed ID: 31399170
    [Abstract] [Full Text] [Related]

  • 20. Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria.
    Ludwig DR, Fraum TJ, Cannella R, Tsai R, Naeem M, LeBlanc M, Salter A, Tsung A, Fleckenstein J, Shetty AS, Borhani AA, Furlan A, Fowler KJ.
    HPB (Oxford); 2019 Dec 03; 21(12):1697-1706. PubMed ID: 31262487
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.